Cencora, Inc. (COR)

Cencora, Inc. (COR) is a healthcare company (medical distribution) based in the United States. The share price is $353.64, down 0.93% on the day, which values the company at $67.48B. Price as of 17 Nov 2026, 17:15 UTC, from Yahoo Finance.

Key facts

Share price
$353.64−0.93% today
Market value
$67.48B
P/E ratio
19.7×last 12 months
Forward P/E
16.3×
Dividend yield
0.67%
Funk Score
61/100
Against its own history
Well above its usual priceusual price $189.89
200-week average
$256.0238% above

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Cencora, Inc. in more detail

COR trades at 19.7× its last twelve months' earnings, 16.3× next year's expected earnings, 0.2× sales. Measured against its own history, the price is 86% above what its usual multiples would imply ($189.89) — well above its usual price. It sits 38% above its 200-week average of $256.02.

Over the last five fiscal years Cencora, Inc. has compounded revenue 11.1% a year, free cash flow 11.8% a year. Its Funk Score is 61 out of 100 (financial strength 7.3, profitability 5.0, growth 7.0, value 5.2, each out of 10).

In its favour: Altman Z in the safe zone; Share count keeps falling.

3 of the superinvestors tracked here hold COR, including Steve Cohen (0.3% of the portfolio), Ken Griffin (0.2% of the portfolio), Israel Englander (0.2% of the portfolio).

Superinvestors holding COR

3 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:COR vs TAK (Cencora, Inc. vs Takeda Pharmaceutical)COR vs BSX (Cencora, Inc. vs Boston Scientific)COR vs CAH (Cencora, Inc. vs Cardinal Health)COR vs ARGX (Cencora, Inc. vs argenx)COR vs EW (Cencora, Inc. vs Edwards Lifesciences)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Cencora, Inc. (COR): questions and answers

What is COR's P/E ratio?

Cencora, Inc. trades at 19.7× its last twelve months' earnings and 16.3× next year's expected earnings. At its fiscal year-ends over the past 16 years the P/E ranged from 12.2× to 66.6×, with a median of 19.3×.

What is COR's PEG ratio?

Cencora, Inc.'s PEG ratio is 0.79 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Cencora, Inc.'s market cap?

Cencora, Inc. is valued at $67.48B at a share price of $353.64.

Is COR overvalued or undervalued?

Against its own history, COR is well above its usual price: the price is 86% above the $189.89 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is COR above its 200-week moving average?

Yes. COR is 38.1% above its 200-week average of $256.02. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Cencora, Inc. growing?

Over the last five fiscal years Cencora, Inc.'s revenue grew 11.1% a year; over ten years revenue grew 9.0% a year.

Cite this page

Funkfolio, “Cencora, Inc. (COR) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/COR

Underlying data: Yahoo Finance; company filings with the SEC.